CellChorus

The dynamic single-cell analysis company

Houston, United States · Founded 2020 · $7.2M raised

Headquarters
Houston, Texas
Employees
1–10
Founded
2020
Total Funding
$7.2M
Last Round
$400K GrantSep 2025
Rounds
9

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 9 funding rounds and 5 investors for this company. The full record is or through the API.

About

At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy). Hear from the team at https://www.youtube.com/watch?v=IE9x_tm0XnI

Summary

CellChorus is a Drug Discovery company based in Houston, United States, founded in 2020. It has raised $7.2M in total across 9 rounds, most recently a $400K Grant round in Sep 2025. Investors include National Center for Advancing Translational Sciences (NCATS), National Science Foundation and National Institute of General Medical Sciences (NIGMS).

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase I (NIH)Sep 2025
$400K

Sign up to see all 9 events

Funding: Angel through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CellChorus on Indexed.vc
<a href="https://indexed.vc/companies/cellchorus"><img src="https://indexed.vc/api/badge/company/cellchorus" alt="CellChorus on Indexed.vc" width="260" height="76" /></a>